Nissinen E[au] - Search Results

Year	Number of Results
1975	1
1978	3
1979	1
1980	3
1981	1
1982	2
1983	1
1984	5
1985	3
1986	2
1987	3
1988	8
1989	4
1990	1
1991	1
1992	3
1993	1
1994	1
1995	3
1997	2
1999	2
2002	2
2003	1
2004	1
2005	2
2006	2
2007	3
2008	3
2010	3
2024	0

1

Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors.

Nissinen E, Männistö PT. Nissinen E, et al. Int Rev Neurobiol. 2010;95:73-118. doi: 10.1016/B978-0-12-381326-8.00005-3. Int Rev Neurobiol. 2010. PMID: 21095460 Review.

2

Introductory remarks: Catechol-O-methyltransferase inhibition--an innovative approach to enhance L-dopa therapy in Parkinson's disease with dual enzyme inhibition.

Nissinen E. Nissinen E. Int Rev Neurobiol. 2010;95:1-5. doi: 10.1016/B978-0-12-381326-8.00001-6. Int Rev Neurobiol. 2010. PMID: 21095456 Review.

3

Antieosinophilic activity of simendans.

Kankaanranta H, Zhang X, Tumelius R, Ruotsalainen M, Haikala H, Nissinen E, Moilanen E. Kankaanranta H, et al. Among authors: nissinen e. J Pharmacol Exp Ther. 2007 Oct;323(1):31-8. doi: 10.1124/jpet.107.124057. Epub 2007 Jul 9. J Pharmacol Exp Ther. 2007. PMID: 17620456

4

Catechol-O-methyltransferase activity in human and rat small intestine.

Nissinen E, Tuominen R, Perhoniemi V, Kaakkola S. Nissinen E, et al. Life Sci. 1988;42(25):2609-14. doi: 10.1016/0024-3205(88)90330-x. Life Sci. 1988. PMID: 3386403

5

The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa.

Kaakkola S, Männistö PT, Nissinen E, Vuorela A, Mäntylä R. Kaakkola S, et al. Among authors: nissinen e. Acta Neurol Scand. 1985 Oct;72(4):385-91. doi: 10.1111/j.1600-0404.1985.tb00888.x. Acta Neurol Scand. 1985. PMID: 4082903 Clinical Trial.

6

Depression and school performance in middle adolescent boys and girls.

Fröjd SA, Nissinen ES, Pelkonen MU, Marttunen MJ, Koivisto AM, Kaltiala-Heino R. Fröjd SA, et al. Among authors: nissinen es. J Adolesc. 2008 Aug;31(4):485-98. doi: 10.1016/j.adolescence.2007.08.006. Epub 2007 Oct 18. J Adolesc. 2008. PMID: 17949806

7

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase.

Männistö PT, Kaakkola S, Nissinen E, Linden IB, Pohto P. Männistö PT, et al. Among authors: nissinen e. Life Sci. 1988;43(18):1465-71. doi: 10.1016/0024-3205(88)90258-5. Life Sci. 1988. PMID: 3185103

8

Determination of cyclic nucleotide phosphodiesterase activity by high-performance liquid chromatography.

Alajoutsijärvi A, Nissinen E. Alajoutsijärvi A, et al. Among authors: nissinen e. Anal Biochem. 1987 Aug 15;165(1):128-32. doi: 10.1016/0003-2697(87)90209-0. Anal Biochem. 1987. PMID: 2446523

9

Effects of entacapone and tolcapone on mitochondrial membrane potential.

Haasio K, Koponen A, Penttilä KE, Nissinen E. Haasio K, et al. Among authors: nissinen e. Eur J Pharmacol. 2002 Oct 18;453(1):21-6. doi: 10.1016/s0014-2999(02)02383-x. Eur J Pharmacol. 2002. PMID: 12393055

10

Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection.

Schultz E, Nissinen E, Kaakkola S. Schultz E, et al. Among authors: nissinen e. Biomed Chromatogr. 1989 Mar;3(2):64-7. doi: 10.1002/bmc.1130030205. Biomed Chromatogr. 1989. PMID: 2736320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year